Abstract
Activated platelets shed microparticles, which contain a variety of growth factors central to angiogenesis and neurogenesis. The aim of this study was to explore whether platelet derived microparticles (PMP) can boost endogenous neural stem cells dependent repair mechanisms following stroke in a rat model.
To examine the effects of PMP therapy in-vivo, we delivered PMP or vehicle via a biodegradable polymer to the brain surface after permanent middle cerebral artery occlusion (PMCAO) in rats.
Rats were tested with the neurological severity score and infarct volumes were measured at 90 days post-ischemia. Immunohistochemistry was used to determine the fate of newborn cells and to count blood vessels in the ischemic brain.
The results show that PMP led to a dose dependent increase in cell proliferation, neurogenesis and angiogenesis at the infarct boundary zone and significantly improved behavioral deficits.
Keywords: Angiogenesis, Cerebral ischemia, Microparticles, Neurogenesis, Platelets, Stroke, endogenous, fibroblastic, platelet microparticles, neural stem cell, brain-derived neurotrophic factor (BDNF), subcellualr fragments, endothelial, PMP, PLX-5A
Current Neurovascular Research
Title:Platelet Microparticles Induce Angiogenesis and Neurogenesis after Cerebral Ischemia
Volume: 9 Issue: 3
Author(s): Yael Hayon, Olga Dashevsky, Ela Shai, Alex Brill, David Varon and Ronen R. Leker
Affiliation:
Keywords: Angiogenesis, Cerebral ischemia, Microparticles, Neurogenesis, Platelets, Stroke, endogenous, fibroblastic, platelet microparticles, neural stem cell, brain-derived neurotrophic factor (BDNF), subcellualr fragments, endothelial, PMP, PLX-5A
Abstract: Activated platelets shed microparticles, which contain a variety of growth factors central to angiogenesis and neurogenesis. The aim of this study was to explore whether platelet derived microparticles (PMP) can boost endogenous neural stem cells dependent repair mechanisms following stroke in a rat model.
To examine the effects of PMP therapy in-vivo, we delivered PMP or vehicle via a biodegradable polymer to the brain surface after permanent middle cerebral artery occlusion (PMCAO) in rats.
Rats were tested with the neurological severity score and infarct volumes were measured at 90 days post-ischemia. Immunohistochemistry was used to determine the fate of newborn cells and to count blood vessels in the ischemic brain.
The results show that PMP led to a dose dependent increase in cell proliferation, neurogenesis and angiogenesis at the infarct boundary zone and significantly improved behavioral deficits.
Export Options
About this article
Cite this article as:
Hayon Yael, Dashevsky Olga, Shai Ela, Brill Alex, Varon David and R. Leker Ronen, Platelet Microparticles Induce Angiogenesis and Neurogenesis after Cerebral Ischemia, Current Neurovascular Research 2012; 9 (3) . https://dx.doi.org/10.2174/156720212801619018
DOI https://dx.doi.org/10.2174/156720212801619018 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vitamin D and the Adaptive Immune System with Special Emphasis to Allergic Reactions and Allograft Rejection
Inflammation & Allergy - Drug Targets (Discontinued) A Central Role for ATP Signalling in Glial Interactions in the CNS
Current Drug Targets Glycolipids as Immune Modulatory Tools
Mini-Reviews in Medicinal Chemistry Evaluation of Venom as a Promising Tool for Drug Discovery: Focusing on Neurological Disorders
Venoms and Toxins Indoleamine 2,3-Dioxygenase in Materno-Fetal Interaction
Current Drug Metabolism Calorie Restriction and Dietary Restriction Mimetics: A Strategy for Improving Healthy Aging and Longevity
Current Pharmaceutical Design Graphical Abstracts
Current Neuropharmacology The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases
Current Pharmaceutical Design Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy
Current Gene Therapy Treatment of Inflammatory Diseases with Mesenchymal Stem Cells
Inflammation & Allergy - Drug Targets (Discontinued) Transient Opening of the Blood-Brain Barrier by Vasoactive Peptides to Increase CNS Drug Delivery: Reality Versus Wishful Thinking?
Current Neuropharmacology Chondroitin Sulfate, a Major Niche Substance of Neural Stem Cells, and Cell Transplantation Therapy of Neurodegeneration Combined with Niche Modification
Current Stem Cell Research & Therapy Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Current Neuropharmacology The Role of Microbiota and Intestinal Permeability in the Pathophysiology of Autoimmune and Neuroimmune Processes with an Emphasis on Inflammatory Bowel Disease Type 1 Diabetes and Chronic Fatigue Syndrome
Current Pharmaceutical Design Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery (Discontinued) The Role of Stem Cells in Muscular Dystrophies
Current Gene Therapy Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective
Current Neurovascular Research Etiological and Biological Aspects of Cigarette Smoking in Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) The Anandamide Degradation System as Potential Target for the Treatment of Central Nervous System Related Disorders
Current Medicinal Chemistry - Central Nervous System Agents Comparison of Isolation, Expansion and Cryopreservation Techniques to Produce Stem Cells from Human Exfoliated Deciduous Teeth (SHED) with Better Regenerative Potential
Current Stem Cell Research & Therapy